Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
Brain Research
|
February 7, 1992
Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes
M Del Zompo, M P Piccardi, S Ruiu, et al.
Brain Research
|
July 23, 1986
Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies
M Del Zompo, M P Piccardi, F Bernardi, et al.
Journal of Neurochemistry
|
April 1, 1996
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum
A Colzi, A Musolino, A Iuliano, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1986
Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro
G U Corsini, S Pintus, A Bocchetta, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1986
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase
G U Corsini, S Pintus, A Bocchetta, et al.
Journal of Neurochemistry
|
September 1, 1985
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro
A Bocchetta, M P Piccardi, M Del Zompo, et al.
Journal of Neurochemistry
|
February 4, 1999
Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses
F Fornai, F S Giorgi, M G Alessandrì, et al.
Psychopharmacology
|
October 31, 1978
Parkinsonism by haloperidol and piribedil
G U Corsini, M Del Zompo, A Spissu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 1997
Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions
F Fornai, M G Alessandrì, M T Torracca, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 22, 1999
G protein-linked receptors: pharmacological evidence for the formation of heterodimers
R Maggio, P Barbier, A Colelli, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
Brain Research
|
February 7, 1992
Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes
M Del Zompo, M P Piccardi, S Ruiu, et al.
Brain Research
|
July 23, 1986
Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies
M Del Zompo, M P Piccardi, F Bernardi, et al.
Journal of Neurochemistry
|
April 1, 1996
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum
A Colzi, A Musolino, A Iuliano, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1986
Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro
G U Corsini, S Pintus, A Bocchetta, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1986
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase
G U Corsini, S Pintus, A Bocchetta, et al.
Journal of Neurochemistry
|
September 1, 1985
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro
A Bocchetta, M P Piccardi, M Del Zompo, et al.
Journal of Neurochemistry
|
February 4, 1999
Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses
F Fornai, F S Giorgi, M G Alessandrì, et al.
Psychopharmacology
|
October 31, 1978
Parkinsonism by haloperidol and piribedil
G U Corsini, M Del Zompo, A Spissu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 1997
Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions
F Fornai, M G Alessandrì, M T Torracca, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 22, 1999
G protein-linked receptors: pharmacological evidence for the formation of heterodimers
R Maggio, P Barbier, A Colelli, et al.
Page
of 8